跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21 条关于
“Calliditas”
全部
21
临床试验
0
药物
0
机构
3
资讯
18
4年前
Calliditas Reports Positive Phase III Results for Nefecon, Plans Full FDA Approval Filing in 2023
去年
Calliditas Therapeutics Pioneered Novel Endpoint for IgAN Drug Approval
5个月前
Calliditas Therapeutics Presents New NefIgArd Trial Data Supporting Nefecon's Gut-Targeted Mechanism in IgA Nephropathy
去年
Phase 3 Success: Nefecon Shows Promise in Treating IgA Nephropathy, Filing Planned for Early 2021
2年前
NOX Inhibitors Show Promise in Fibrotic Diseases and Cancer Treatment
去年
Hansa Biopharma Appoints Renée Aguiar-Lucander as New CEO, Marking New Growth Phase
去年
Liver Cirrhosis Pipeline Shows Strong Growth with 30+ Therapies in Development Across Multiple Clinical Phases
去年
New Podcast 'Kidney Compass' Launches to Navigate Complex Landscape of Nephrology Clinical Trials
去年
Taiwan TFDA Approves Nefecon for Primary IgA Nephropathy Treatment
去年
EMA Panel Recommends Sparsentan for IgA Nephropathy, Paving Way for EU Approval
第 1 页,共 2 页
上一页
下一页